Reuters logo
a month ago
BRIEF-Theraclion’s Echopulse covered by French National Health insurance for the treatment of breast fibroadenomas
July 12, 2017 / 4:16 PM / a month ago

BRIEF-Theraclion’s Echopulse covered by French National Health insurance for the treatment of breast fibroadenomas

July 12 (Reuters) - THERACLION SA:

* THERACLION’S ECHOPULSE® COVERED BY FRENCH NATIONAL HEALTH INSURANCE FOR THE TREATMENT OF BREAST FIBROADENOMAS

* THIS FLAT-RATE COVERAGE IS FOR PERIOD OF 4 YEARS, INCLUDING 1 YEAR OF INCLUSION PERIOD, 1.5 YEARS OF FOLLOW-UP, 6 MONTHS OF DATA ANALYSIS

* THIS FLAT-RATE COVERAGE INCLUDES ALSO 1 YEAR OF RE-EVALUATION PROCESSES BY THE FRENCH’S NATIONAL HEALTH AUTHORITY (HAS)

* AMOUNT OF PACKAGE INCLUDES PATIENT CARE AND ASSOCIATED HOSPITALIZATION EXPENSES AND IS THUS SET PER PATIENT AT EUR 1,300

* SIX HUNDRED PATIENTS, AMONG WHICH 150 WITHIN THE STUDY, WILL BE ELIGIBLE FOR THIS COVERAGE

* TWELVE HIGHLY REPUTED CENTERS FROM ALL OVER FRANCE, BOTH FROM THE PRIVATE AND THE PUBLIC SECTOR, WILL PARTICIPATE IN THE STUDY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below